Cite
Targeting -Acetyl-GD2 Ganglioside for Cancer Immunotherapy.
MLA
Fleurence, Julien, et al. “Targeting -Acetyl-GD2 Ganglioside for Cancer Immunotherapy.” Journal of Immunology Research, Jan. 2017, pp. 1–16. EBSCOhost, https://doi.org/10.1155/2017/5604891.
APA
Fleurence, J., Fougeray, S., Bahri, M., Cochonneau, D., Clémenceau, B., Paris, F., Heczey, A., Birklé, S., Clémenceau, B., & Birklé, S. (2017). Targeting -Acetyl-GD2 Ganglioside for Cancer Immunotherapy. Journal of Immunology Research, 1–16. https://doi.org/10.1155/2017/5604891
Chicago
Fleurence, Julien, Sophie Fougeray, Meriem Bahri, Denis Cochonneau, Béatrice Clémenceau, François Paris, Andras Heczey, Stéphane Birklé, Béatrice Clémenceau, and Stéphane Birklé. 2017. “Targeting -Acetyl-GD2 Ganglioside for Cancer Immunotherapy.” Journal of Immunology Research, January, 1–16. doi:10.1155/2017/5604891.